Healthcare
Impel Pharmaceuticals
Late-stage biopharmaceutical company that optimizes drug delivery for central nervous system diseases using its proprietary nasal drug delivery technology
Classification
HealthcareHealth Care Growth
Ownership timeline
Transaction records
2018Portfolio Record
KKR investment in Impel Pharmaceuticals
Late-stage biopharmaceutical company that optimizes drug delivery for central nervous system diseases using its proprietary nasal drug delivery technology
- Target
- Impel Pharmaceuticals
- Buyer
- KKR
- Value
- Not publicly established
deep record0 named people